EXTRACORPOREAL TECHNIQUES IN THE TREATMENT OF POISONED PATIENTS .9.

被引:48
作者
POND, SM
机构
[1] University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, QLD 4102, Ipswich Road
关键词
D O I
10.5694/j.1326-5377.1991.tb121225.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of haemodialysis, haemoperfusion and haemofiltration in the management of poisoned patients is reviewed in light of 15 years' clinical experience. During haemodialysis, blood is pumped across a semipermeable membrane (dialysis) through which the compound diffuses and, during haemoperfusion, through a cartridge that contains activated charcoal to which the compound is adsorbed. During haemofiltration, the constituents of blood that have a relative molecular mass which is below the cut-off point of the hollow fibre membrane (usually less than 40 000) are extracted. Haemofiltration is indicated particularly for aminoglycoside toxicity. The clearance by these three procedures depends on the physicochemical characteristics and kinetics of the toxic compound. In general, if a compound is adsorbed by charcoal, the clearance by haemoperfusion will be higher than that achieved by haemodialysis. Similarly, if a compound is amenable to removal by haemodialysis, its clearance will be greater than that achieved by haemofiltration. The indications for extracorporeal elimination depend on the clinical severity and complications of the overdose, the characteristics of the individual patient and the nature, dose and plasma concentrations of the toxic substance. It is generally accepted that extracorporeal elimination is worthwhile if it increases total body clearance by 30% or more. It has little or no value for intoxication caused by chloroquine, flecainide, methotrexate, paraquat, quinine, and tricyclic antidepressants. The complications of extracorporeal elimination which are encountered most frequently are: hypotension; blood loss; haematomas; metabolic disequilibria; mechanical problems such as air embolism; and, in the case of haemoperfusion, hypocalcaemia, thrombocytopenia and leukopenia. In practice, the compounds for which extracorporeal elimination is used most frequently are the alcohols, lithium and salicylate (haemodialysis) and theophylline (haemofiltration).
引用
收藏
页码:617 / 622
页数:6
相关论文
共 63 条
[1]   CLINICAL-FEATURES AND MANAGEMENT OF LITHIUM POISONING [J].
AMDISEN, A .
MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1988, 3 (01) :18-32
[2]   CHARCOAL HEMOPERFUSION FOR THE TREATMENT OF A COMBINED DILTIAZEM AND METOPROLOL OVERDOSE [J].
ANTHONY, T ;
JASTREMSKI, M ;
ELLIOTT, W ;
MORRIS, G ;
PRASAD, H .
ANNALS OF EMERGENCY MEDICINE, 1986, 15 (11) :1344-1348
[3]  
BATEMAN DN, 1985, Q J MED, V54, P125
[4]   ACUTE DAPSONE INTOXICATION - A CASE TREATED WITH CONTINUOUS INFUSION OF METHYLENE-BLUE, FORCED DIURESIS AND PLASMA-EXCHANGE [J].
BERLIN, G ;
BRODIN, B ;
HILDEN, JO ;
MARTENSSON, J .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1984, 22 (06) :537-548
[5]   MASSIVE THYROXINE INTOXICATION - EVALUATION OF PLASMA EXTRACTION [J].
BINIMELIS, J ;
BASSAS, L ;
MARRUECOS, L ;
RODRIGUEZ, J ;
DOMINGO, MLP ;
MADOZ, P ;
ARMENGOL, S ;
MANGUES, MA ;
DELEIVA, A .
INTENSIVE CARE MEDICINE, 1987, 13 (01) :33-38
[6]  
BISMUTH C, 1979, VET HUM TOXICOL, V21, P2
[7]  
BOWSHER DJ, 1985, J LAB CLIN MED, V105, P489
[8]   FAILURE OF HEMOPERFUSION TO REDUCE FLECAINIDE INTOXICATION - A CASE-STUDY [J].
BRAUN, J ;
KOLLERT, JR ;
GESSLER, U ;
BECKER, JU .
MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1987, 2 (06) :463-467
[9]   QUININE INTOXICATION IN A CHILD TREATED BY EXCHANGE TRANSFUSION [J].
BURROWS, AW ;
WILSON, BDR ;
HARDMAN, MJ ;
HAMBLETON, G .
ARCHIVES OF DISEASE IN CHILDHOOD, 1972, 47 (252) :304-+
[10]   POTENTIAL PITFALLS IN THE EVALUATION OF THE USEFULNESS OF HEMODIALYSIS FOR THE REMOVAL OF LITHIUM [J].
CLENDENINN, NJ ;
POND, SM ;
KAYSEN, G ;
BARRAZA, JJ ;
FARRELL, T ;
BECKER, CE .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1982, 19 (04) :341-352